Cystic fibrosis: Molecular approaches to diagnosis

Annals of Clinical and Laboratory Science

Volumn 28, Issue 6, 1998, Pages 380-385

  Makowski, Gregory S ^a   Hopfer, Sidney M ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHORUS 32; SULFUR 35; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; GENE MUTATION; GENETIC DISORDER; GENOME; HUMAN; ISOTOPE LABELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

BLOOD SPECIMEN COLLECTION; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA; HUMANS; NEONATAL SCREENING; POLYMERASE CHAIN REACTION;

EID: 0031795861     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Cystic Fibrosis Genetic Analysis Consortium. The (1990) worldwide survey of the ΔF508 mutation-report form the cystic fibrosis genetic analysis consortium. Am J Hum Genet 1990;47:354-9.
2. Verlingue C, Mercier B, Lecoq I, Audrezet MP, Laroche D, Travert G, Ferec C. Retrospective study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Guthrie cards from a large cohort of neonatal screening for cystic fibrosis. Hum Genet 1994;93:429-34.
3. Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
4. Kerem B-S, Zielenski J, Markiewicz D, Bozon D, Gazit E, Yahav J, Kennedy D, Riordan JR, Collins FS, Rommens JM, Tsui L-C. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci 1990;87:8447-51.
5. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63: 827-34.
6. Tsui L-C. The spectrum of cystic fibrosis mutations. Trends Genet 1992;8:392-8.
7. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-4.
8. Zielenski J, Tsui L-C. Cystic fibrosis: genotypic and phenotypic variations. Ann Rev Genet 1995;29:333-8.
9. Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation-screening practices. Am J Hum Genet 1998;62:1252-4.
10. Stern RC. Current concepts: the diagnosis of cystic fibrosis. New Engl J Med 1997;336:487-91.
11. Wilmott RW. Making the diagnosis of cystic fibrosis. J Pediatr 1998;132:563-5.
12. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Meth Enzymol 1987;155:335-50.
13. Balnaves ME, Nasioulas S, Dahl H-HM, Forrest S. Direct PCR from CVS and blood lysates for detection of cystic fibrosis and Duchenne muscular dystrophy deletions. Nucl Acids Res 1991;19:1155.
14. Liu J, Lissens W, Dilber SJ, Devroey P, Liebaers I, Van Steirteghem A. Birth after preimplantation diagnosis of the cystic fibrosis ΔF508 mutation by polymerase chain reaction in human embryos resulting from intracytoplasmic sperm injection with epididymal sperm. J Am Med Assn 1994;272:1858-60.
15. Makowski GS, Aslanzadeh J, Hopfer SM. In situ PCR amplification of Guthrie card DNA to detect cystic flbrosis mutations. Clin Chem 1995;41:447-9.
16. Williams C, Weber L, Williamson R, Hjelm M. Guthrie spots for DNA-based carrier testing in cystic fibrosis. Lancet 1988;ii:693.
17. Lyonnet S, Caillaud C, Rey F, Berthelon M, Freza J, Rey J, Munnich A. Guthrie cards for detection of point mutations in phenylketonuria. Lancet 1988;ii:507.
18. Jinks DC, Minter M, Tarver DA, Vanderford M, Hejtmancik JF, McCabe ERB. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum Genet 1989;81:363-6.
19. Yokota M, Tatsumi N, Tsuda I, Yano I. DNA extraction and amplification from giemsa-stained blood smears. J Clin Lab Anal 1995;9:387-91.
20. Guthrie R. Organization of a regional newborn screening laboratory. In: Bickel H, Guthrie R, Hammersen G, eds. Neonatal Screening for Inborn Errors of Metabolism. New York: Springer, 1980:259-70.
21. Crossley JR, Smith PA, Edgar BW, Gluckman PD, Elliott RB. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spot. Clin Chim Acta 1981;113:111-21.
22. McCabe ERB, Huang S-Z, Seltzer WK, Law ML. DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum Genet 1987;75:213-6.
23. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. BioTechniques 1991; 10:506-13.
24. Raskin S, Phillips JA III, Dawson E, Kaplan G, McClure M, Vnencak-Jones C. Cystic fibrosis genotyping by direct PCR analysis of Guthrie card blood spots. PCR Meth Appl 1992;2:154-6.
25. Schneeberger C, Kury F, Larsen J, Speiser P, Zeillinger R. A simple method for extraction of DNA from Guthrie cards. PCR Meth Appl 1992;2:177-9.
26. Makowski GS, Aslanzadeh J, Hopfer SM. Mini-gel PAGE for enhanced resolution of polymerase chain reaction detection of DF508 deletion in cystic fibrosis. Grin Chem 1993;39:2204-5.
27. Yang M, Hendrie HC, Hall KS, Oluwole OSA, Hodes ME, Sahota A. Improved procedure for eluting DNA from dried blood spots. Clin Chem 1996;42:1115-6.
28. Makowski GS, Davis EL, Hopfer SM. Enhanced direct amplification of Guthrie card DNA following selective elution of PCR inhibitors. Nucl Acids Res 1995;23:3788-9.
29. Makowski GS, Davis ERL, Hopfer SM. Amplification of Guthrie card DNA: effect of guanidine thiocyanate on binding of natural whole blood PCR inhibitors. J Clin Lab Anal 1997;11:87-93.
30. Makowski GS, Davis EL, Nadeau F, Hopfer SM. Polymerase chain reaction amplification of Guthrie card deoxyribonucleic acid: extraction of nucleic acid from filter matrices. Ann Clin Lab Sci 1996;28:254-9.
31. Plaha DS, Linforth GH, Duckett DP, Scott-Jupp R, Tanner MS, Jeffreys AJ. Three-base pair resolution of DNA fragments on agarose: application to delta F508 analysis in cystic fibrosis. BioTechniques 1993;14: 566-7.
32. Rommens J, Kerem B-S, Greer W, Chang P, Tsui L-C, Ray P. Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet 1990; 46:395-6.
33. Serre JL, Taillandier A, Mornet E, Simon-Bouy B, Boue J, Boue A. Nearly 80 percent of cystic fibrosis heterozygotes and 64 percent of couples at risk may be detected through a unique screening of four mutations by ASO reverse dot blot. Genomics 1991;11: 1149-51.
34. Coutlee F, Saint-Antoine P, Olivier C, Voyer H, Kessous-Elbaz A, Berrada F, Begin P, Giroux L, Viscidi R. Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA. J Clin Microbiol 1991; 29:2461-7.
35. Lanzillo JL. Chemiluminescent nucleic acid detection with digoxigenin-labelled probes: a model system with probes for angiotensin converting enzyme which detect less than one attomole of target DNA. Anal Biochem 1991;194:45-53.
36. Murakami A, Nakaura M, Nakatsuji Y, Nagahara S, Tran-Cong Q, Makino K. Fluorescent-labeled oligonucleotide probes: detection of hybrid formation in solution by fluorescence polarization spectroscopy. Nucl Acids Res 1991;19:4097-102.
37. Iitia A, Hogdall E, Dahlen P, Hurskainen P, Vuust J, Siitari H. Detection of mutation DF508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry. PCR Meth Appl 1992;2: 157-62.
38. Iitia A, Liukkonen L, Siitari H. Simultaneous detection of two cystic fibrosis alleles using dual-label time-resolved fluorometry. Molec Cell Probes 1992;6:505-12.
39. 32P-labelled oligodeoxy-nucleotide probes. Molec Cell Probes 1991;5:117-24.
40. Coutlee F, Viscidi RP, Yolken RH. Comparison of colorimetric, fluorescent and enzymatic amplification substrate systems in an enzyme immunoassay for detection of DNA-RNA hybrids. J Clin Microbiol 1989;27:1002-7.
41. Kricka LJ. Chemiluminescent and bioluminescent techniques. Clin Chem 1991;37:1472-81.
42. Mantero G, Zonaro A, Albertini A, Bertolo P, Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem 1991;37:422-9.
43. Mazza C, Mantero G, Primi D. DNA enzyme immunoassay: a rapid and convenient colorimetric method for diagnosis of cystic fibrosis. Molec Cell Probes 1991;5:459-66.
44. Imberti L, Sottini A, Bettinardi A, Mazza C, Albertini A, Primi D. Nonradioisotopic methods for DNA probes. Ann Biol Clin 1992;50:163-7.
45. Hopfer SM, Makowski GS, Davis EL, Aslanzadeh J. Detection of cystic fibrosis ΔF508 mutation by anti-double-stranded DNA antibody. Ann Clin Lab Sci 1995;25:475-84.
46. McEwen JE, Reilly PR. Stored Guthrie cards as DNA "banks." Am J Hum Genet 1994;55:196-200.
47. Makowski GS, Davis EL, Hopfer SM. The effect of storage on Guthrie cards: implications for deoxyribonucleic acid amplification. Ann Clin Lab Sci 1996;26: 458-69.
48. Landegren U, Kaiser R, Caskey CT, Hood L. DNA diagnostics - molecular techniques and automation. Science 1988;242:229-37.
49. Belgrader P, Del Rio SA, Turner KA, Marino MA, Weaver KR, Williams PE. Automated DNA purification and amplification from blood-stained cards using a robotic workstation. Biotechniques 1995;19:426-32.
50. Tamary H, Surrey S, Kirschmann H, Shalmon L, Zaizov R, Schwartz E, Rappaport EF. Systematic use of automated fluorescence-based sequence analysis of amplified genomic DNA for rapid detection of point mutations. Am J Hematol 1994;46:127-33.
51. Jalanko A, Kere J, Savilahti E, Schwartz M, Syvanen A-C, Ranki M, Soderlund H. Screening for defined cystic fibrosis mutations by solid-phase minisequencing. Clin Chem 1992;38:39-43.
52. DeMarchi JM, Beaudet AL, Caskey CT, Richards CS. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations. Arch Pathol Lab Med 1994;118:26-32.
53. Cheng J, Sheldon EL, Wu L, Uribe A, Gerrue LO, Carrino J, Heller MJ, O'Connell JP. Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips. Nature Biotechnol 1998;16:541-46.
54. Kricka LJ. Revolution on a square centimeter. Nature Biotechnol 1998;16:513-4.
55. Lester LA, Kraut J, Lloyd-Still J, Karrison T, Mott C, Billstrand C, Lemke A, Ober C. ΔF508 Genotype does not predict disease severity in an ethnically diverse cystic fibrosis population. Pediatrics 1994;93: 114-8.
56. Desgeorges M, Kjellberg P, Demaille J, Claustres M. A health male with compound and double heterozygosities for ΔF508, ΔF508C, and M470V in exon 10 of the cystic fibrosis gene. Am J Hum Genet 1994;54: 384-5.
57. Kiesewetter S, Macek S, Davis C, Curristin SM, Chu C-S, Graham C, Shrimpton AE, Cashman SM, Tsui L-C, Mickle J, Amos J, Highsmith WE, Shuber A, Witt DR, Crystal RG, Cutting GR. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993;5:274-8.